V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002102 | 230009343 | 1.57 | 62.6 | Curative (C) | null | 2021-12-30 | null | 02 | N | CISPLATIN + LIPOSOMAL DOXORUBICIN | 101463180 |
| 230002104 | 230009344 | 1.53 | 72.4 | null | null | 2018-04-13 | Rucaparib | 02 | null | RUCAPARIB | 100649146 |
| 230002109 | 230009345 | 1.63 | 101 | null | null | 2021-11-04 | DOXORUBICIN | 02 | null | NIVOLUMAB | 100812027 |
| 230002115 | 230009348 | 1.53 | 60.2 | null | 2022-01-10 | 2022-01-24 | Rucaparib | 02 | null | RUCAPARIB | 100114246 |
| 230002117 | 230009350 | 1.52 | 75 | Palliative (P) | 2019-02-06 | 2019-07-26 | null | 02 | N | CYCLOPHOSPHAMIDE | 100477391 |
| 230002121 | 230009351 | null | null | null | null | 2021-09-23 | Niraparib | 02 | null | NIRAPARIB | 100231171 |
| 230002123 | 230009352 | 1.6 | 86.5 | Palliative (P) | 2019-11-25 | 2019-12-17 | PACLITAXEL | 02 | N | PACLITAXEL | 100941032 |
| 230002124 | 230009353 | 1.7 | 55 | null | 2020-07-04 | 2020-07-04 | PACLITAXEL | 02 | null | PACLITAXEL | 100318201 |
| 230002125 | 230009354 | 1.56 | 63 | null | 2019-11-25 | 2019-12-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101100497 |
| 230002127 | 230009355 | null | null | null | null | 2021-07-15 | Doxorubicin 75mg/m2 | 02 | null | IPILIMUMAB | 101755948 |
| 230002129 | 230009357 | 1.62 | 98.3 | null | 2019-07-04 | 2019-07-09 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101432037 |
| 230002130 | 230009358 | 1.65 | 55.6 | null | 2021-01-24 | 2021-04-08 | null | 02 | null | TRIAL UNSPECIFIED | 100943287 |
| 230002134 | 230009360 | 1.53 | 92.4 | Palliative (P) | 2022-03-07 | 2022-03-11 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100359729 |
| 230002139 | 230009362 | 1.54 | 77 | null | 2019-03-21 | 2020-02-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100761734 |
| 230002141 | 230009363 | 1.68 | 99 | Adjuvant (A) | null | 2022-01-22 | null | null | N | CISPLATIN + PACLITAXEL | 101257171 |
| 230002146 | 230009366 | 1.6 | 155.3 | null | 2022-02-09 | 2022-04-24 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100649868 |
| 230002153 | 230009371 | null | null | null | 2021-10-14 | 2021-10-28 | Etoposide oral | 02 | null | NIVOLUMAB | 100775832 |
| 230002159 | 230009373 | 1.61 | 74.5 | Palliative (P) | 2019-09-01 | 2019-09-01 | Olaparib | 02 | N | OLAPARIB | 101786518 |
| 230002170 | 230009375 | null | null | null | null | 2020-08-15 | null | null | null | RUCAPARIB | 100451950 |
| 230002179 | 230009377 | 1.68 | 55 | null | 2021-10-23 | 2021-10-28 | null | null | null | PACLITAXEL | 100556662 |
| 230002180 | 230009378 | null | null | Palliative (P) | 2022-03-18 | 2022-04-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100470366 |
| 230002182 | 230009379 | null | null | null | 2022-05-15 | 2022-05-22 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101006413 |
| 230002183 | 230009380 | 1.63 | 45.2 | null | null | 2017-01-17 | null | null | null | PACLITAXEL | 100308560 |
| 230002184 | 230009381 | 1.65 | 72.8 | null | null | 2020-02-09 | Trial Unspecified | 02 | null | FLUOROURACIL + IRINOTECAN | 100731831 |
| 230002187 | 230009382 | 1.59 | 57.8 | Adjuvant (A) | 2019-11-01 | 2020-04-14 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100767357 |
| 230002190 | 230009383 | null | null | Palliative (P) | null | 2022-03-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101409364 |
| 230002191 | 230009384 | 1.54 | 92 | null | 2020-09-07 | 2020-09-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101547711 |
| 230002196 | 230009386 | 1.6 | 79 | null | null | 2021-09-21 | null | null | null | DICE TRIAL | 100917034 |
| 230002199 | 230009387 | 1.65 | 66.4 | null | 2022-03-27 | 2022-04-10 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100988405 |
| 230002213 | 230009389 | 1.62 | 72 | null | 2020-07-17 | 2021-03-26 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100396177 |
| 230002219 | 230009391 | null | null | Palliative (P) | 2021-02-08 | 2021-02-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100788570 |
| 230002223 | 230009392 | 1.57 | 63.2 | null | 2022-02-05 | 2022-04-04 | null | 01 | null | NIRAPARIB | 101466493 |
| 230002233 | 230009395 | 1.74 | 94.2 | Neo-adjuvant (N) | 2021-06-22 | 2021-07-18 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101079093 |
| 230002234 | 230009396 | null | null | null | 2020-03-18 | 2020-06-03 | IPILIMUMAB + NIVOLUMAB | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101273499 |
| 230002236 | 230009397 | 1.47 | 48.6 | null | 2019-05-20 | 2021-11-12 | Rucaparib | 02 | null | RUCAPARIB | 100590159 |
| 230002240 | 230009399 | null | null | null | 2021-05-25 | 2021-11-11 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101504664 |
| 230002252 | 230009402 | 1.52 | 91.6 | null | 2018-11-01 | 2020-07-20 | ICON8 TRIAL | 02 | null | ICON8B TRIAL | 101589084 |
| 230002254 | 230009403 | 1.62 | 70 | null | null | 2022-03-13 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100931203 |
| 230002257 | 230009404 | 1.58 | 78 | null | 2021-05-02 | 2021-05-16 | null | 02 | null | CARBOPLATIN + LIPOSOMAL DOX | 100731899 |
| 230002258 | 230009405 | 1.62 | 64.7 | null | 2020-03-24 | 2020-04-08 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100778972 |
| 230002264 | 230009408 | 1.67 | 81.3 | null | 2020-02-27 | 2020-03-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101792400 |
| 230002266 | 230009409 | 1.62 | 93.8 | Palliative (P) | null | 2021-08-05 | Cisplatin + Etoposide po | 02 | N | TRIAL UNSPECIFIED | 101259615 |
| 230002269 | 230009410 | 1.64 | 94.5 | null | 2021-12-26 | 2022-01-14 | null | null | null | NIRAPARIB | 100652381 |
| 230002272 | 230009411 | 1.69 | 78.2 | null | 2020-11-03 | 2020-11-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101277414 |
| 230002274 | 230009412 | 1.53 | 84.9 | null | 2021-03-12 | 2021-03-21 | Bevacizumab | 02 | null | BEVACIZUMAB | 100560810 |
| 230002277 | 230009413 | 1.52 | 59.5 | null | 2019-07-23 | 2019-08-12 | PACLITAXEL | 02 | null | PACLITAXEL | 101787983 |
| 230002284 | 230009415 | null | null | null | 2022-02-25 | 2022-03-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100866680 |
| 230002285 | 230009416 | 1.63 | 66.3 | null | 2020-10-24 | 2020-10-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100895698 |
| 230002286 | 230009417 | null | null | null | 2017-05-21 | 2019-05-07 | Olaparib | 02 | null | TRIAL UNSPECIFIED | 100750655 |
| 230002288 | 230009418 | 1.58 | 59 | Palliative (P) | null | 2020-10-12 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101757498 |